1. Home
  2. RDY vs ATI Comparison

RDY vs ATI Comparison

Compare RDY & ATI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDY
  • ATI
  • Stock Information
  • Founded
  • RDY 1984
  • ATI 1960
  • Country
  • RDY India
  • ATI United States
  • Employees
  • RDY N/A
  • ATI N/A
  • Industry
  • RDY Biotechnology: Pharmaceutical Preparations
  • ATI Steel/Iron Ore
  • Sector
  • RDY Health Care
  • ATI Industrials
  • Exchange
  • RDY Nasdaq
  • ATI Nasdaq
  • Market Cap
  • RDY 11.6B
  • ATI 11.2B
  • IPO Year
  • RDY N/A
  • ATI N/A
  • Fundamental
  • Price
  • RDY $13.88
  • ATI $98.33
  • Analyst Decision
  • RDY Strong Buy
  • ATI Strong Buy
  • Analyst Count
  • RDY 1
  • ATI 7
  • Target Price
  • RDY $16.90
  • ATI $105.43
  • AVG Volume (30 Days)
  • RDY 1.1M
  • ATI 1.6M
  • Earning Date
  • RDY 10-24-2025
  • ATI 10-28-2025
  • Dividend Yield
  • RDY 0.51%
  • ATI N/A
  • EPS Growth
  • RDY 9.95
  • ATI 18.88
  • EPS
  • RDY 0.79
  • ATI 3.10
  • Revenue
  • RDY $3,851,623,984.00
  • ATI $4,583,000,000.00
  • Revenue This Year
  • RDY $6.29
  • ATI $6.53
  • Revenue Next Year
  • RDY $2.61
  • ATI $8.03
  • P/E Ratio
  • RDY $17.55
  • ATI $31.63
  • Revenue Growth
  • RDY 14.10
  • ATI 7.75
  • 52 Week Low
  • RDY $12.26
  • ATI $39.23
  • 52 Week High
  • RDY $16.17
  • ATI $103.64
  • Technical
  • Relative Strength Index (RSI)
  • RDY 49.14
  • ATI 64.21
  • Support Level
  • RDY $13.37
  • ATI $93.87
  • Resistance Level
  • RDY $13.52
  • ATI $99.00
  • Average True Range (ATR)
  • RDY 0.24
  • ATI 3.37
  • MACD
  • RDY 0.02
  • ATI -0.16
  • Stochastic Oscillator
  • RDY 49.31
  • ATI 61.51

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

About ATI ATI Inc.

ATI Inc supplies specialty metals to various end markets, including aerospace and defense, oil and gas, automotive, and electrical energy, among many others. The company's operating segment includes High-Performance Materials and Components and Advanced Alloys and Solutions. The majority of revenue is from the High-Performance Materials segment. The High-Performance Materials segment is focused on a wide range of high-performance specialty materials, parts, and components for several the majority of end markets, including the aerospace & defense, medical, and energy markets. Geographically, it operates in the United States, China, the United Kingdom, Germany, France, Canada, and Others, the majority is from the United States.

Share on Social Networks: